Cargando…
Substance P promotes immunotherapy efficacy for airway allergy()
BACKGROUND: Allergen-specific immunotherapy (AIT) has been employed in the treatment of allergic diseases for many years. However, the effectiveness of AIT requires improvement. Substance P (SP) can interact with immune cells, modulate immune cell activity, and regulate immune reaction. The purpose...
Autores principales: | Wu, Yongjin, Liu, Yu, Wang, Xinxin, Liu, Huazhen, Wu, Gaohui, Yang, Liteng, Guan, Li, Huang, Qinmiao, Zeng, Xianhai, Yang, Pingchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791926/ https://www.ncbi.nlm.nih.gov/pubmed/36601262 http://dx.doi.org/10.1016/j.waojou.2022.100730 |
Ejemplares similares
-
Semaphorin-3 Promotes Specific Immunotherapy Effects on Experimental Food Allergy
por: Huang, Huang, et al.
Publicado: (2022) -
TAFA4-IL-10 axis potentiate immunotherapy for airway allergy by induction of specific regulatory T cells
por: Qiu, Shuyao, et al.
Publicado: (2022) -
XBP1 is required in Th2 polarization induction in airway allergy
por: Zeng, Xianhai, et al.
Publicado: (2022) -
Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
por: Zeng, Yinhui, et al.
Publicado: (2023) -
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy
por: Brozek, Jan L., et al.
Publicado: (2022)